ANURAS

Anupam Rasayan India Limited

Specialty chemicals and custom synthesis manufacturer for life sciences and performance materials

Commodities›Chemicals›Chemicals & Petrochemicals›Specialty Chemicals

anupamrasayan.com(opens the company website in a new tab)
Ask AI

Key metrics

Price as of 2026-10-16

Stock price
₹1176.00
Market cap
13,404 Cr
Stock P/E
76.7
P/B
4.02
Dividend yield
0.1%
ROE (FY26)
3.7%
ROCE (FY26)
6.3%
Operating margin (FY26)
16.3%
Debt / equity (FY26)
0.54
OCF / EBITDA (FY26)
63.7%
OCF / EBITDA (3Y)
27.8%

Full years shown; sign in free for the trailing twelve months. Learn about these metrics →

Price & valuation

Share price and valuation multiples (P/E, P/B and more) over time.

Loading price history…

Compare with peers

Loading peers…

What you need to know

Anupam Rasayan makes complex specialty chemicals and intermediates, through multi-step synthesis, for global innovator customers in agrochemicals, pharmaceuticals, personal care and performance materials such as semiconductor and electronic chemicals.

Company snapshot

10thBy market cap

Ranked among 68 companies in Specialty Chemicals.

What we see

Concerns
  • ✗Only 28% of operating profit came in as cash over the last three years — much of it is tied up in unpaid bills or stock.

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Sales392 Cr296 Cr401 Cr254 Cr294 Cr390 Cr500 Cr486 Cr731 Cr512 Cr636 Cr655 Cr
Operating expenses (approx.)285 Cr216 Cr308 Cr201 Cr214 Cr266 Cr356 Cr362 Cr596 Cr385 Cr498 Cr493 Cr
EBITDA107 Cr79 Cr93 Cr53 Cr80 Cr124 Cr144 Cr124 Cr136 Cr127 Cr137 Cr162 Cr
OPM %27.4%26.8%23.1%20.9%27.4%31.9%28.9%25.6%18.6%24.9%21.6%24.8%
Other income3 Cr2 Cr12 Cr6 Cr2 Cr-4 Cr6 Cr5 Cr8 Cr2 Cr3 Cr13 Cr
Interest20 Cr25 Cr26 Cr22 Cr27 Cr32 Cr31 Cr36 Cr36 Cr35 Cr42 Cr49 Cr
Depreciation20 Cr20 Cr21 Cr21 Cr22 Cr29 Cr31 Cr31 Cr32 Cr34 Cr43 Cr56 Cr
Profit before tax71 Cr36 Cr58 Cr16 Cr34 Cr59 Cr88 Cr63 Cr76 Cr60 Cr56 Cr70 Cr
Tax %31.1%27.5%30.1%24.7%10.0%8.9%28.6%22.9%24.3%-1.1%0.1%26.5%
Net profit49 Cr26 Cr40 Cr12 Cr31 Cr54 Cr63 Cr48 Cr57 Cr61 Cr56 Cr51 Cr
EPS (₹)₹3.78₹1.70₹2.81₹0.36₹1.51₹2.57₹4.06₹3.10₹3.93₹4.31₹3.75₹3.39

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales501 Cr529 Cr811 Cr1,066 Cr1,602 Cr1,475 Cr1,437 Cr2,365 CrSign in free for the trailing twelve months
Operating expenses (approx.)408 Cr394 Cr617 Cr769 Cr1,171 Cr1,094 Cr1,036 Cr1,841 CrSign in free for the trailing twelve months
EBITDA93 Cr135 Cr194 Cr297 Cr431 Cr381 Cr401 Cr525 CrSign in free for the trailing twelve months
OPM %18.6%25.5%23.9%27.9%26.9%25.8%27.9%22.2%Sign in free for the trailing twelve months
Other income19 Cr11 Cr26 Cr15 Cr9 Cr30 Cr11 Cr18 CrSign in free for the trailing twelve months
Interest24 Cr45 Cr69 Cr31 Cr63 Cr89 Cr112 Cr149 CrSign in free for the trailing twelve months
Depreciation23 Cr29 Cr52 Cr60 Cr71 Cr80 Cr102 Cr140 CrSign in free for the trailing twelve months
Profit before tax65 Cr71 Cr100 Cr222 Cr308 Cr242 Cr198 Cr254 CrSign in free for the trailing twelve months
Tax %23.9%25.8%29.7%31.4%29.5%30.7%19.1%12.7%Sign in free for the trailing twelve months
Net profit49 Cr53 Cr70 Cr152 Cr217 Cr167 Cr160 Cr222 CrSign in free for the trailing twelve months
EPS (₹)₹6.60₹6.94₹8.56₹15.22₹20.91₹11.89₹8.50₹15.09Sign in free for the trailing twelve months
Dividend payout %——0.0%6.6%11.3%15.7%8.4%6.8%Sign in free for the trailing twelve months
Sign in free for the trailing twelve months

The latest four quarters added up, next to each full year

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity capital50 Cr50 Cr100 Cr100 Cr107 Cr110 Cr110 Cr146 Cr
Reserves457 Cr544 Cr1,473 Cr1,627 Cr2,265 Cr2,651 Cr2,740 Cr3,188 Cr
Borrowings617 Cr761 Cr387 Cr796 Cr788 Cr1,020 Cr1,318 Cr1,815 Cr
Other liabilities199 Cr309 Cr338 Cr368 Cr482 Cr651 Cr869 Cr1,568 Cr
Total liabilities1,323 Cr1,664 Cr2,298 Cr2,891 Cr3,778 Cr4,602 Cr5,269 Cr8,013 Cr
Fixed assets (net)668 Cr925 Cr1,103 Cr1,191 Cr1,280 Cr1,357 Cr2,038 Cr2,980 Cr
CWIP191 Cr101 Cr43 Cr44 Cr120 Cr609 Cr216 Cr114 Cr
Investments0.40 Cr0.40 Cr0.02 Cr149 Cr67 Cr67 Cr9 Cr19 Cr
Loans & advances——11 Cr4 Cr15 Cr3 Cr2 Cr2 Cr
Inventories195 Cr297 Cr492 Cr863 Cr931 Cr1,055 Cr1,452 Cr1,775 Cr
Trade receivables121 Cr129 Cr205 Cr280 Cr415 Cr579 Cr734 Cr959 Cr
Cash & bank2 Cr20 Cr241 Cr42 Cr188 Cr250 Cr113 Cr378 Cr
Other assets146 Cr191 Cr201 Cr318 Cr762 Cr682 Cr705 Cr1,786 Cr
Total assets1,323 Cr1,664 Cr2,298 Cr2,891 Cr3,778 Cr4,602 Cr5,269 Cr8,013 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activity39 Cr95 Cr1 Cr-171 Cr292 Cr59 Cr-30 Cr334 Cr
Cash from investing-250 Cr-178 Cr-193 Cr-412 Cr-523 Cr-392 Cr-330 Cr-820 Cr
Cash from financing206 Cr101 Cr416 Cr384 Cr371 Cr395 Cr223 Cr621 Cr
Net cash flow-6 Cr18 Cr224 Cr-199 Cr140 Cr62 Cr-137 Cr135 Cr
Free cash flow (OCF − Capex)-209 Cr-85 Cr-145 Cr-318 Cr71 Cr-657 Cr-440 Cr-221 Cr

Ratios

MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
ROCE %7.9%8.6%8.6%10.0%11.2%8.4%7.0%6.3%
ROE %9.7%8.9%4.5%8.8%7.2%4.4%3.0%3.7%
Debtor days8889929694143186148
Inventory days279367382454442556564448
Days payable105161155120153219224239
Cash conversion cycle261295319430383480526357
OCF / EBITDA %41.8%70.4%0.8%-57.6%67.7%15.5%-7.5%63.7%
OCF / EBITDA % (3 years)——32.1%-12.0%13.3%16.2%26.5%27.8%
Debt / equity1.221.280.250.460.330.370.460.54
Current ratio1.251.122.652.432.601.691.421.43
Net debt / EBITDA6.605.500.752.541.392.023.012.74